For over the last 20 years, AstraZeneca was the manufacturer of one of the largest selling breast cancer drugs in the world: Nolvadex (tamoxifen citrate). (According to a notice posted at
www.nolvadex.com, Nolvadex is no longer manufactured or sold in the United States as of June 2006; however, the drug's generic form tamoxifen citrate is still available).
Nolvadex is not a cure for cancer. It has been heavily prescribed as a drug to lessen the risk of reoccurrence in women who have previously received treatment for breast cancer.
It was also approved for use as a "risk reduction" drug (the FDA would not allow the term "prevention"), and prescribed to women with no presence of breast cancer who are considered to be at elevated risk.
This drug has been very profitable for AstraZeneca, with sales over $400 million annually, but it is also a very controversial drug. It has significant side effects that have been linked to uterine cancer, liver cancer, heart disease, osteoporosis, depression, eye damage, blood clots, and even breast cancer--the very condition it is supposed to treat!
But the story doesn't stop there.
AstraZeneca (ICI) is a chemical giant, and is one of the world's top producers of organochlorides, which are chlorine-based industrial chemicals. Organochlorides are used in the manufacture of a wide variety of compounds, including Agent Orange, PCB's, and DDT.
Organochlorides are also known carcinogens, and studies have found them to be specifically associated with increased incidence of breast cancer.
So here we have a corporation--a very large and profitable corporation with sales of $14 billion in 1998-- that makes its money from industrial chemicals that cause cancer and drugs that treat (and potentially cause) cancer. Incidentally, they also have a large financial stake in cancer treatment centers.
This brings us to another major criticism of NBCAM: the focus of their efforts is almost exclusively on detection and treatment of breast cancer, not on prevention.
This only makes sense since their main financial backer is a huge corporation that makes a fortune off the treatment of a disease they contribute to causing.
But beyond that, breast cancer and cancers in general can be prevented through changes in diet and lifestyle, like staying away from chemicals and drugs that cause cancer! The problem with this is that prevention is very inexpensive and not very profitable.
One more interesting thing about AstraZeneca's relationship with NBCAM is that part of the arrangement allows AstraZeneca to approve and/or veto any marketing materials related to NBCAM.
Thus, you will not find anything related to environmental causes of breast cancer or how it can be prevented by avoiding exposure to them. The American Cancer Society minimizes the cancer risks from industrial chemicals and pesticides, and will not take a stand on environmental regulation. It is a very carefully controlled Public Relations ploy.